UP To Be Major Hub Of Pharma Products: CM Yogi

Lucknow: Chief minister Yogi Adityanath on Friday said that from being a pharma consumer state, Uttar Pradesh was fast moving towards becoming a major producer and exporter of pharmaceutical products.

Laying the foundation stone for a pharmacy building at the Madan Mohan Malviya University of Technology in Gorakhpur, the CM said that the govt was building a Pharma Park spread over 2,000 acre in Lalitpur and was also planning to develop a Medical Device Park.

“Barring the reluctance and lack of determination of the then state leadership to develop UP, the state has had all the resources to push it to this level of development. The state is the same, the people are the same, the machinery is also the same. But when the work culture changes, results become evident. Today, UP has emerged as a new and transformed state. It has become a state of progress and investment. There are ample opportunities and possibilities for progress in every sector,” the CM said.

While distributing smartphones and tablets to students, the CM said that they should be enterprising enough to grab every opportunity that comes their way as it was only with faith and perseverance that one could think of achieving the impossible.

Elaborating on the Swami Vivekananda Youth Empowerment Scheme under which he distributed phones and tablets, the CM said that this was being done to make youth technologically competent. Around two crore youth would be given phones and tablets under this scheme, the CM said, adding that the devices would incorporate vital govt initiatives, aimed at fostering self-reliance in the youth.

“By becoming technically competent, the youth will move forward and contribute in realising Prime Minister Narendra Modi’s vision of a developed India. Technically skilled youth will play a significant role in building a developed India,” the CM said.

Reflecting on the legacy of Madan Mohan Malviya, the founder of the Benaras Hindu University, the CM said that the university, named in his honour, was consistently making strides towards success. In line with the PM’s vision of self-reliance, it was building the pharmacy with its own resources, the CM said.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre